188 related articles for article (PubMed ID: 33266617)
21. Visceral and subcutaneous abdominal fat is associated with non-alcoholic fatty liver disease while augmenting Metabolic Syndrome's effect on non-alcoholic fatty liver disease: A cross-sectional study of NHANES 2017-2018.
Elguezabal Rodelo RG; Porchia LM; Torres-Rasgado E; López-Bayghen E; Gonzalez-Mejia ME
PLoS One; 2024; 19(2):e0298662. PubMed ID: 38394065
[TBL] [Abstract][Full Text] [Related]
22. Noninvasive Diagnosis of Nonalcoholic Fatty Liver Disease and Quantification of Liver Fat with Radiofrequency Ultrasound Data Using One-dimensional Convolutional Neural Networks.
Han A; Byra M; Heba E; Andre MP; Erdman JW; Loomba R; Sirlin CB; O'Brien WD
Radiology; 2020 May; 295(2):342-350. PubMed ID: 32096706
[TBL] [Abstract][Full Text] [Related]
23. Association of epicardial fat volume and nonalcoholic fatty liver disease with metabolic syndrome: From the CAESAR study.
Kim BJ; Kim HS; Kang JG; Kim BS; Kang JH
J Clin Lipidol; 2016; 10(6):1423-1430.e1. PubMed ID: 27919360
[TBL] [Abstract][Full Text] [Related]
24. Cardio-Metabolic Indices and Metabolic Syndrome as Predictors of Clinical Severity of Gastroenteropancreatic Neuroendocrine Tumors.
Barrea L; Muscogiuri G; Modica R; Altieri B; Pugliese G; Minotta R; Faggiano A; Colao A; Savastano S
Front Endocrinol (Lausanne); 2021; 12():649496. PubMed ID: 33815296
[TBL] [Abstract][Full Text] [Related]
25. Ultrasound Sample Entropy Imaging: A New Approach for Evaluating Hepatic Steatosis and Fibrosis.
Chan HJ; Zhou Z; Fang J; Tai DI; Tseng JH; Lai MW; Hsieh BY; Yamaguchi T; Tsui PH
IEEE J Transl Eng Health Med; 2021; 9():1800612. PubMed ID: 34786215
[No Abstract] [Full Text] [Related]
26. Noninvasive Diagnosis of Nonalcoholic Fatty Liver Disease and Quantification of Liver Fat Using a New Quantitative Ultrasound Technique.
Lin SC; Heba E; Wolfson T; Ang B; Gamst A; Han A; Erdman JW; O'Brien WD; Andre MP; Sirlin CB; Loomba R
Clin Gastroenterol Hepatol; 2015 Jul; 13(7):1337-1345.e6. PubMed ID: 25478922
[TBL] [Abstract][Full Text] [Related]
27. The anti-inflammatory potential of diet and nonalcoholic fatty liver disease: the ATTICA study.
Tyrovolas S; Panagiotakos DB; Georgousopoulou EN; Chrysohoou C; Skoumas J; Pan W; Tousoulis D; Pitsavos C
Therap Adv Gastroenterol; 2019; 12():1756284819858039. PubMed ID: 31258620
[TBL] [Abstract][Full Text] [Related]
28. Comparison of noninvasive scoring systems for the prediction of nonalcoholic fatty liver disease in metabolic syndrome patients.
Saokaew S; Kositamongkol C; Charatcharoenwitthaya P; Srivanichakorn W; Washirasaksiri C; Chaiyakunapruk N; Phisalprapa P
Medicine (Baltimore); 2020 Dec; 99(50):e23619. PubMed ID: 33327335
[TBL] [Abstract][Full Text] [Related]
29. Ultrasonographic fatty liver indicator detects mild steatosis and correlates with metabolic/histological parameters in various liver diseases.
Ballestri S; Nascimbeni F; Baldelli E; Marrazzo A; Romagnoli D; Targher G; Lonardo A
Metabolism; 2017 Jul; 72():57-65. PubMed ID: 28641784
[TBL] [Abstract][Full Text] [Related]
30. Ultrasound Assessment of Hepatic Steatosis by Using the Double Nakagami Distribution: A Feasibility Study.
Fang F; Fang J; Li Q; Tai DI; Wan YL; Tamura K; Yamaguchi T; Tsui PH
Diagnostics (Basel); 2020 Aug; 10(8):. PubMed ID: 32759867
[TBL] [Abstract][Full Text] [Related]
31. Relation of nonalcoholic fatty liver disease to the metabolic syndrome: the Multi-Ethnic Study of Atherosclerosis.
Zeb I; Katz R; Nasir K; Ding J; Rezaeian P; Budoff MJ
J Cardiovasc Comput Tomogr; 2013; 7(5):311-8. PubMed ID: 24268118
[TBL] [Abstract][Full Text] [Related]
32. Development and validation of a clinical and laboratory-based nomogram to predict nonalcoholic fatty liver disease.
Cen C; Wang W; Yu S; Tang X; Liu J; Liu Y; Zhou L; Yu J; Zheng S
Hepatol Int; 2020 Sep; 14(5):808-816. PubMed ID: 32572817
[TBL] [Abstract][Full Text] [Related]
33. MRI-determined liver fat correlates with risk of metabolic syndrome in patients with nonalcoholic fatty liver disease.
Chen J; Duan S; Ma J; Wang R; Chen J; Liu X; Xue L; Xie S; Yao S
Eur J Gastroenterol Hepatol; 2020 Jun; 32(6):754-761. PubMed ID: 32091437
[TBL] [Abstract][Full Text] [Related]
34. Nonalcoholic Fatty Liver Disease for Identification of Preclinical Carotid Atherosclerosis.
Sinn DH; Cho SJ; Gwak GY; Cho J; Gu S; Seong D; Kang D; Kim H; Yi BK; Paik SW
Medicine (Baltimore); 2016 Jan; 95(3):e2578. PubMed ID: 26817915
[TBL] [Abstract][Full Text] [Related]
35. Skeletal muscle mass and abdominal obesity are independent predictors of hepatic steatosis and interact to predict ten-year cardiovascular disease incidence: Data from the ATTICA cohort study.
Kouvari M; Polyzos SA; Chrysohoou C; Skoumas J; Pitsavos CS; Panagiotakos DB; Mantzoros CS
Clin Nutr; 2022 Jun; 41(6):1281-1289. PubMed ID: 35504171
[TBL] [Abstract][Full Text] [Related]
36. [Diagnostic significance of clinical and laboratory indices in predicting non-alcoholic fatty liver disease during screening studies].
Nosov AE; Zenina MT; Gorbushina OY; Baidina AS; Vlasova EM; Alekseev VB
Ter Arkh; 2021 Aug; 93(8):883-889. PubMed ID: 36286882
[TBL] [Abstract][Full Text] [Related]
37. Comparison of fatty liver index with noninvasive methods for steatosis detection and quantification.
Zelber-Sagi S; Webb M; Assy N; Blendis L; Yeshua H; Leshno M; Ratziu V; Halpern Z; Oren R; Santo E
World J Gastroenterol; 2013 Jan; 19(1):57-64. PubMed ID: 23326163
[TBL] [Abstract][Full Text] [Related]
38. Quantitative Ultrasound Radiofrequency Data Analysis for the Assessment of Hepatic Steatosis in Nonalcoholic Fatty Liver Disease Using Magnetic Resonance Imaging Proton Density Fat Fraction as the Reference Standard.
Jeon SK; Lee JM; Joo I; Park SJ
Korean J Radiol; 2021 Jul; 22(7):1077-1086. PubMed ID: 33739636
[TBL] [Abstract][Full Text] [Related]
39. Perirenal fat thickness and liver fat fraction are independent predictors of MetS in adults with overweight and obesity suspected with NAFLD: a retrospective study.
Wang L; Pan Y; Ye X; Zhu Y; Lian Y; Zhang H; Xu M; Liu M; Ruan X
Diabetol Metab Syndr; 2023 Mar; 15(1):56. PubMed ID: 36949492
[TBL] [Abstract][Full Text] [Related]
40. AGA Clinical Practice Update: Diagnosis and Management of Nonalcoholic Fatty Liver Disease in Lean Individuals: Expert Review.
Long MT; Noureddin M; Lim JK
Gastroenterology; 2022 Sep; 163(3):764-774.e1. PubMed ID: 35842345
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
